Eam Global Investors LLC Avidity Biosciences, Inc. Transaction History
Eam Global Investors LLC
- $435 Million
- Q3 2024
A detailed history of Eam Global Investors LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Eam Global Investors LLC holds 117,171 shares of RNA stock, worth $5.11 Million. This represents 1.24% of its overall portfolio holdings.
Number of Shares
117,171
Previous 116,615
0.48%
Holding current value
$5.11 Million
Previous $4.76 Million
12.98%
% of portfolio
1.24%
Previous 1.18%
Shares
2 transactions
Others Institutions Holding RNA
# of Institutions
256Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$464 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$403 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$376 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$355 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$307 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.28B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...